Lung Cancer
Mesothelioma of the Left Thorax
Male, 45 years
Patient Internal ID:335379601
ICD-10 code
C45.0 Mesothelioma of Pleura
Diagnosis (Incl. Metastases/Stage) and Year
December 2016
Mesothelioma of the Left Thorax cT4N1M1 Ki67 20% Stage IV. Tumor invasion to the Pericardium, Metastases to Paraaortic Lymph Nodes, Spleen.
Previous Treatment
Chemotherapy (FLOT scheme), Surgery (Gastrectomy), HIPEC (Cisplatin), Chemotherapy (FOLFOX scheme).
Prognosis and Survival Expectation
Surgery (Thoracotomy), Chemotherapy (Cisplatin/ Pemetrexed), Chemotherapy (Cisplatin/ Gemcitabine), Chemotherapy (Carboplatin/ Gemcitabine).
Treatment Provided
Pleural Mesothelioma prognosis is generally poor. The disease has a median survival of eight to 14 months. Five-year survival is 12% for all stages combined.
Patient Survival/Condition and Year
Date of Review: 30/12/2023
The patient has survived for 54 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation therapy, has extended patient survival by an estimate of around 40 months.
